摘要
目的：比较米氮平片与舍曲林片治疗抑郁症患者的疗效、主观体验。方法：将76例抑郁症患者随机分为2组，米氮平组，舍曲林组。每组38例，疗效6周，于治疗前及治疗2周、4周、6周末采用HAMD抑郁量表评定临床疗效，TESS（症状量表）评定不良反应及安全性。结果：米氮平组和舍曲林组抑郁量表总分较前有显著下降（P〈0．01），但米氮平片组2周末汉密顿抑郁量表总分较舍曲林组下降更显著（P〈0．05或0．01）。结论：米氮平和舍曲林治疗抑郁症疗效相当，米氮平起效较快。
Objective：Comparison of Mirtazapine tablets and Sertraline tablets in the treatment of depressive patients, sub ejective experience. Methods： 76patients with depression were randomly divided into two groups, mirtazapine, sertraline group, 38 cases in each treatment six weeks, before treatment and 2weeks of treatment,4weeks,6weeks using the HAMD depression amount table to evaluate the clinical efficacy and TESS（Symptom Scale） assessment of adverse reactions and safety. Result：Depression Rating Scale total score of the rnirtazapine group and sertraline group decreased significantly（P〈0.01） ,compared with the previous mirtazapine two weekends,the Hamilton Depression Rating Scale total score than the sertraline group decreased more significantly（P〈0.05 or 0.01）. Conclusion： Quite mirtazapine sertraline treatment of depression, mirtazapine, rapid onset.
出处
《按摩与康复医学》
2012年第15期90-90,共1页
Chinese Manipulation and Rehabilitation Medicine
